Cannahealth in St Kilda, Victoria | Health & wellness website

Cannahealth

Locality: St Kilda, Victoria

Phone: +61 1300 122 662

Add/Update information

Reviews

Tags

• Medical and health
• Medical service
• Health & wellness website

21.01.2022 Cannagewell.com A New Medicinal Cannabis Clinic Focusing Patients Aged 50+ Embracing a holistic approach, Dr Gipps (but you can call him Dr Steve) draws on 36 years of experience in general practice, urgent care, internal medicine and occupational medicine including 10 years in the USA. From initial student days, exposure to biofeedback, Shiatsu massage, acupuncture and many other natural therapies helps in sorting out what non-conventionally prescribed therapies may be of be...nefit. Minimizing prescription medication is always a goal yet clear recommendations on what is best not omitted, is given. Musculoskeletal, sports/ work injuries, mental well being and pain management are some special interests. Life choices, diet, exercise and relationship health are high priority topics for discussion. Connectivity with our creator and lover/ healer is acknowledged as the pinnacle source for wisdom, health and well being. If you have a medicinal cannabis inquiry call 1300 122 662 or email [email protected] (The information contained on this website is not an inducement to use Medicinal Cannabis. Please be aware that medicinal cannabis does not work for everyone. If you believe that medicinal cannabis may help your symptom and/or condition, please seek medical advice.)

20.01.2022 What is CBG? As doctors continue to get their heads around CBD and THC, we at Cannahealth and CANNATREK are reluctant to talk about any other component of the cannabis plant. However, for some relaxed morning reading, here is an article about CBG published by The Green Fund. If you have a medicinal cannabis inquiry call 1300 122 662 or email [email protected]... (The information contained on this website is not an inducement to use Medicinal Cannabis. Please be aware that medicinal cannabis does not work for everyone. If you believe that medicinal cannabis may help your symptom and/or condition, please seek medical advice.)

18.01.2022 Canada-based healthcare technology firm Cannalogue has applied to Health Canada seeking approval for a real-world clinical trial of medical cannabis to treat Covid-19. The trial is intended to assess if medical cannabis could mitigate the symptoms caused by Covid-19 infection or any mutant coronavirus strains. If you have a medicinal cannabis inquiry call 1300 122 662 or email [email protected]... (The information contained on this website is not an inducement to use Medicinal Cannabis. Please be aware that medicinal cannabis does not work for everyone. If you believe that medicinal cannabis may help your symptom and/or condition, please seek medical advice.) https://www.clinicaltrialsarena.com//cannalogue-manitoba-/

16.01.2022 One of Australia's premier cannabis doctors, Dr John Teh of PlantMed Australia talking access on Channel 9. If you have a medicinal cannabis inquiry call 1300 122 662 or email [email protected] (The information contained on this website is not an inducement to use Medicinal Cannabis. Please be aware that medicinal cannabis does not work for everyone. If you believe that medicinal cannabis may help your symptom and/or condition, please seek medical advice.)

16.01.2022 In this article published bu Medical Cannabis Network, integrative medicine expert, Dr Dani Gordon, presents a balanced article answering peoples’ question of whether cannabis and CBD can affect contracting or recovering from COVID-19, or coronavirus. If you have a medicinal cannabis inquiry call 1300 122 662 or email [email protected] (The information contained on this website is not an inducement to use Medicinal Cannabis. Please be aware that medicinal cannabis does not work for everyone. If you believe that medicinal cannabis may help your symptom and/or condition, please seek medical advice.)

14.01.2022 Just came across this great info-graphic showing THC and CBD formulations, conditions that may be effective for, and their expected level of psycho-activity :

14.01.2022 Maintaining Mental Health in the Time of COVID-19 a webinar series - Cannadoc Join this Thursday the 2nd of April, 2020 at 1pm for an exciting webinar led by Dr David Feng, a Melbourne GP and the Medical Director of Cannadoc Health. If you’re like most Australians, you’re probably feeling significant stress and worry right now and it’s understandable. This event is focused on helping and will be delivered in a Q&A format. Attendees can discuss their concerns with Dr Feng w...ho will provide answers/advice on the maintenance of good mental health. Please send us any questions or topics you wish to discuss prior, and we will do our best to get through as many as we can. See you then! If you have a medicinal cannabis inquiry call 1300 122 662 or email [email protected] (The information contained on this website is not an inducement to use Medicinal Cannabis. Please be aware that medicinal cannabis does not work for everyone. If you believe that medicinal cannabis may help your symptom and/or condition, please seek medical advice.)

13.01.2022 Abrupt withdrawal of cannabidiol (CBD): A randomized trial: Some evidence relating to a common patient inquiry "In healthy volunteers, no evidence of withdrawal syndrome was found with abrupt discontinuation of short-term treatment with CBD." If you have a medicinal cannabis inquiry call 1300 122 662 or email [email protected]... (The information contained on this website is not an inducement to use Medicinal Cannabis. Please be aware that medicinal cannabis does not work for everyone. If you believe that medicinal cannabis may help your symptom and/or condition, please seek medical advice.)

12.01.2022 Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal ...cannabis cohort. Baron EP, et al. J Headache Pain. 2018. BACKGROUND: Medicinal cannabis registries typically report pain as the most common reason for use. It would be clinically useful to identify patterns of cannabis treatment in migraine and headache, as compared to arthritis and chronic pain, and to analyze preferred cannabis strains, biochemical profiles, and prescription medication substitutions with cannabis. METHODS: Via electronic survey in medicinal cannabis patients with headache, arthritis, and chronic pain, demographics and patterns of cannabis use including methods, frequency, quantity, preferred strains, cannabinoid and terpene profiles, and prescription substitutions were recorded. Cannabis use for migraine among headache patients was assessed via the ID Migraine questionnaire, a validated screen used to predict the probability of migraine. RESULTS: Of 2032 patients, 21 illnesses were treated with cannabis. Pain syndromes accounted for 42.4% (n = 861) overall; chronic pain 29.4% (n = 598;), arthritis 9.3% (n = 188), and headache 3.7% (n = 75;). Across all 21 illnesses, headache was a symptom treated with cannabis in 24.9% (n = 505). These patients were given the ID Migraine questionnaire, with 68% (n = 343) giving 3 "Yes" responses, 20% (n = 102) giving 2 "Yes" responses (97% and 93% probability of migraine, respectively). Therefore, 88% (n = 445) of headache patients were treating probable migraine with cannabis. Hybrid strains were most preferred across all pain subtypes, with "OG Shark" the most preferred strain in the ID Migraine and headache groups. Many pain patients substituted prescription medications with cannabis (41.2-59.5%), most commonly opiates/opioids (40.5-72.8%). Prescription substitution in headache patients included opiates/opioids (43.4%), anti-depressant/anti-anxiety (39%), NSAIDs (21%), triptans (8.1%), anti-convulsants (7.7%), muscle relaxers (7%), ergots (0.4%). CONCLUSIONS: Chronic pain was the most common reason for cannabis use, consistent with most registries. The majority of headache patients treating with cannabis were positive for migraine. Hybrid strains were preferred in ID Migraine, headache, and most pain groups, with "OG Shark", a high THC (9-tetrahydrocannabinol)/THCA (tetrahydrocannabinolic acid), low CBD (cannabidiol)/CBDA (cannabidiolic acid), strain with predominant terpenes -caryophyllene and -myrcene, most preferred in the headache and ID Migraine groups. This could reflect the potent analgesic, anti-inflammatory, and anti-emetic properties of THC, with anti-inflammatory and analgesic properties of -caryophyllene and -myrcene. Opiates/opioids were most commonly substituted with cannabis. Prospective studies are needed, but results may provide early insight into optimizing crossbred cannabis strains, synergistic biochemical profiles, dosing, and patterns of use in the treatment of headache, migraine, and chronic pain syndromes. https://www.ncbi.nlm.nih.gov/m/pubmed/29797104/

12.01.2022 We have many patients calling out for Australian made medicinal cannabis medication. We can tell you that the day is drawing nearer as evidenced by this story on ABC Landline. If you have a medicinal cannabis inquiry call 1300 122 662 or email [email protected] (The information contained on this website is not an inducement to use Medicinal Cannabis. Please be aware that medicinal cannabis does not work for everyone. If you believe that medicinal cannabis may help your symptom and/or condition, please seek medical advice.)

10.01.2022 Another positive medicinal cannabis story with Md Shahnur Rahman of My Cannabis Clinic in Craignish, QLD.

07.01.2022 IMPROVED ACCESS THOUGH AUSTRALIAN CANNABIS CLINICS (ACC): ACC is a small clinic focused on personalised service. The advisory board is lead by Dr Vanderzwan - previously the head clinician at the largest Canadian clinic chain where he has treated over 1,500 patients with medical cannabis over the years. ACC is utilising this specialised knowledge to fast track better outcomes for patients. - Initial Telehealth consultation (including application) $250.... - Follow up Telehealth consults are bulk billed. Call the clinic at [email protected] If you have a medicinal cannabis inquiry call 1300 122 662 or email [email protected] (The information contained on this website is not an inducement to use Medicinal Cannabis. Please be aware that medicinal cannabis does not work for everyone. If you believe that medicinal cannabis may help your symptom and/or condition, please seek medical advice.)

05.01.2022 CBD prescription - an audit on the first 400 patients in New Zealand: " There may be analgesic and anxiolytic benefits of CBD in patients with non-cancer chronic pain and mental health conditions such as anxiety. CBD is well tolerated, making it safe to trial for non-cancer chronic pain, mental health, neurological, and cancer symptoms." If you have a medicinal cannabis inquiry call 1300 122 662 or email [email protected]... (The information contained on this website is not an inducement to use Medicinal Cannabis. Please be aware that medicinal cannabis does not work for everyone. If you believe that medicinal cannabis may help your symptom and/or condition, please seek medical advice.)

05.01.2022 A new study led by Murdoch Children's Research Institute has found #cannabidiol, a type of #medicinal cannabis, may reduce severe behavioral problems in childre...n and adolescents with an intellectual disability. The pilot study recorded a clinically significant change in participants’ irritability, aggression, self-injury, and yelling. The intervention was also found to be safe and well-tolerated by most study participants. This is the first investigation of cannabidiol to manage severe behavioral problems in children and adolescents with an intellectual disability. Most of the participants also had autism. The findings come as Federal Health Minister Greg Hunt announced MCRI would receive a $883,484 Medical Research Future Fund (MRFF) grant to conduct a large scale randomised placebo-controlled trial study to definitively test the findings as well as the cost-effectiveness of the treatment. https://www.mcri.edu.au//medicinal-cannabis-may-reduce-beh

05.01.2022 RESEARCH SHARE The Effectiveness of Cannabis Flower for Immediate Relief from Symptoms of Depression Yale J Biol Med. 2020 Jun; 93(2): 251264.... CONCLUSIONS The findings suggest that, at least in the short term, the vast majority of patients that use cannabis experience antidepressant effects, although the magnitude of the effect and extent of side effect experiences vary with chemotypic properties of the plant. Read here : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309674/

04.01.2022 Dr Orit Holtzman of Compass Lifestyle Clinics has called for patients to be given easier and cheaper access to medicinal cannabis, claiming it will reduce the harm associated with highly-addictive and potentially deadly opioids. If you have a medicinal cannabis inquiry call 1300 122 662 or email [email protected] (The information contained on this website is not an inducement to use Medicinal Cannabis. Please be aware that medicinal cannabis does not work for everyone. If you believe that medicinal cannabis may help your symptom and/or condition, please seek medical advice.)

01.01.2022 https://merryjane.com//researchers-find-that-cbg-and-cgc-c

01.01.2022 A little wisdom from one of Australia's leading Medical Cannabis focused clinics, CDA Clinics. Enjoy. If you have a medicinal cannabis inquiry call 1300 122 662 or email [email protected] (The information contained on this website is not an inducement to use Medicinal Cannabis. Please be aware that medicinal cannabis does not work for everyone. If you believe that medicinal cannabis may help your symptom and/or condition, please seek medical advice.)